Form 4: Arch Capital Group EVP and CFO, Francois Morin, Reports Stock Option Grant and Share Transactions

Sentiment:

SEC Form 4 Filing


Francois Morin, EVP and CFO of Arch Capital Group Ltd., reports the acquisition of stock options and common shares, as well as the disposal of common shares.

Summary

  • On March 4, 2025, Francois Morin, the EVP and CFO of Arch Capital Group Ltd., filed a Form 4.
  • The filing reports the acquisition of 4,789 common shares at $0 and the disposal of 4,789 common shares.
  • Morin also acquired stock options to purchase 16,945 and 14,788 common shares at an exercise price of $91.87, exercisable in installments starting March 4, 2026, and expiring on March 4, 2035.
  • Following these transactions, Morin directly owns 274,681 common shares, 16,945 stock options and 14,788 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports transactions by an insider, which is a normal course of business. The acquisition of shares and options could be seen as a positive sign, but the disposal of shares offsets this.

Positives

  • The acquisition of stock options demonstrates management's alignment with shareholder interests.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

  • Stock option grants are a common form of executive compensation in the insurance and financial services industries.
  • The vesting schedule of the options (three equal annual installments commencing one year after the grant date) is a typical arrangement.
  • The exercise price of $91.87 would need to be compared to the market price of ACGL shares at the time of the grant to assess the 'moneyness' of the options.

Stakeholder Impact

  • Shareholders may view the insider transactions as a signal of management's confidence in the company.
  • The transactions have a negligible impact on employees, customers, suppliers, and creditors.

Key Dates

DateDescription
03/04/2025Date of earliest transaction and grant date of stock options.
03/04/2026First exercisable date for stock options.
03/04/2027Second exercisable date for stock options.
03/04/2028Third exercisable date for stock options.
03/04/2035Expiration date for stock options.
03/06/2025Date of signature on the Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.